FinancialBuzz.com’s latest Buzz on the Street Show: Featuring Our Corporate News Recap on “Q BioMed Announces $7.5M Grant Benefiting its Preclinical Product Development Pipeline.”
Q BioMed Inc. (OTCQB: QBIO), a commercial stage biotech company, announced today that its technology partner, Mannin, has received a $7.5M grant from the German state of Saxony. Mannin is a research-stage biotechnology company focused on the discovery, development, and commercialization of therapeutics for vascular diseases. It was founded in July 2012 and is led by President and CEO, Dr. George Nikopoulos. Q BioMed and Mannin have been partners since 2015.
Q BioMed Inc. is a biotech acceleration and commercial stage company. We are focused on licensing and acquiring undervalued biomedical assets in the healthcare sector. Q BioMed is dedicated to providing these target assets; strategic resources, developmental support, and expansion capital to ensure they meet their developmental potential, enabling them to provide products to patients in need.
A Fortune Business Insights report, titled “Glaucoma Therapeutics: Global Market Analysis, Insights and Forecast, 2019-2026,” indicates that demand for therapeutics among common consumers will advance the demand for global glaucoma therapeutics. The report states that the value of the glaucoma therapeutics market in North America was worth a total of USD 2.4 Billion in 2018. The glaucoma therapeutics market is anticipated to increase at a CAGR of 6.1% and reach USD 10 Billion by the close of 2026.
“Public authorities and governments are adoption several initiatives to create awareness about glaucoma and aid in the cure and prevention of glaucoma. This is projected to generate demand in the global glaucoma therapeutics market,” said a lead analyst at Fortune Business Insights.
For more information, please visit: Q BioMed Inc.
For more corporate news on Q BioMed Inc., check out the Buzz on the Street
About Buzz on the Street: One of FinancialBuzz.com’s latest corporate and financial news shows, covering the latest trending stock market news. Buzz on the Street looks to become a leader in corporate video news dissemination. Buzz on the Street is 100% original content, brought to you by Financial Buzz Media.